Daily Newsletter

24 November 2023

Daily Newsletter

24 November 2023

Thornhill to boost mobile anaesthesia technology production

The technology has been deployed in critical care scenarios such as Ukraine.

Archana Rani November 24 2023

Canadian medical technology manufacturer Thornhill Medical is planning to boost production of MADM, a mobile gas anaesthesia technology.

The portable inline direct injection gas vaporiser, which received approvals from both the US Food and Drug Administration and Health Canada, is designed to easily connect to any ventilator for easily delivering isoflurane and sevoflurane gas anaesthesia.

Said to be easy to use due to its small footprint, the lightweight technology features compact design making it ideal in more challenging environments such as forward-deployed surgical scenarios and field hospitals.

The vaporiser can easily be hand-carried or attached to Thornhill's MOVES SLC integrated life-support system to stand up a forward surgical capability quickly.

Thornhill president and CEO Lesley Gouldie said: “We know that surgical care in the far-forward setting needs solutions that promote agility, mobility and are self-sufficient while overcoming contested logistics and supply chain interruptions.

“We are also experiencing an increased demand for our MOVES SLC integrated life-support system which is why it is imperative that we are ready to support our combat and humanitarian partners to help save more lives with our companion MADM technology.”

The technology was initially developed with the US Marine Corps as its field anaesthesia system. It has been deployed in critical care scenarios, including in Ukraine.

Capable of automatically adapting its operation to any ventilator type it is connected, the technology has been assessed for field use by the US Army Aeromedical Research Laboratory and Air Force Medical Evaluation Support Activity.

Can Generative AI transform the medical devices industry?

The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation, which has improved efficiencies and enhanced patient outcomes. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns.

Newsletters by sectors


Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.